Literature DB >> 18349520

Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts.

Gessica Sala1, Federica Trombin, Laura Mattavelli, Simone Beretta, Lucio Tremolizzo, Simona Andreoni, Elena Calabrese, Lara Sanvito, Carlo Ferrarese.   

Abstract

BACKGROUND: It is conceivable that an early therapeutic intervention in amyotrophic lateral sclerosis (ALS) would lead to better results in terms of disease progression for these patients. One possible strategy to increase the sensitivity of the diagnosis is represented by the use of biological parameters reflecting, for example, oxidative stress alterations associated with ALS. Such biomarkers would be valuable tools both for a better diagnostic evaluation and for studying the impact of therapeutic interventions on the disease course. A special category of experimental models is represented by peripheral cells obtained directly from patients (ex vivo).
OBJECTIVE: In this study, primary fibroblasts obtained from 10 sporadic ALS (SALS) patients and 10 healthy matched controls were used to investigate a panel of parameters related to the oxidative status.
METHODS: Reactive oxygen species production, protein carbonylation and nitration, susceptibility to hydrogen peroxide exposure, p38-mitogen-activated protein kinase activation and adenosine triphosphate intracellular content were evaluated.
RESULTS: No significant difference was observed in all investigated parameters between patient and control cells, and no correlation with the disease severity was found.
CONCLUSION: Collectively, our data show no major alterations of the oxidative and bioenergetic status in SALS cultured fibroblasts, suggesting that these cells do not represent a useful model to study the oxidative dysfunction associated with SALS. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18349520     DOI: 10.1159/000121390

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  3 in total

1.  Distinct regulation of cell cycle and survival in lymphocytes from patients with Alzheimer's disease and amyotrophic lateral sclerosis.

Authors:  Fernando Bartolomé; Ursula Muñoz; Noemí Esteras; Jesús Esteban; Félix Bermejo-Pareja; Angeles Martín-Requero
Journal:  Int J Clin Exp Pathol       Date:  2008-12-01

2.  Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion.

Authors:  Lucio Tremolizzo; Gessica Sala; Elisa Conti; Virginia Rodriguez-Menendez; Antonella Fogli; Angela Michelucci; Paolo Simi; Silvana Penco; Christian Lunetta; Massimo Corbo; Carlo Ferrarese
Journal:  Case Rep Neurol Med       Date:  2014-07-17

3.  Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes.

Authors:  Gessica Sala; Alessandro Arosio; Elisa Conti; Simone Beretta; Christian Lunetta; Nilo Riva; Carlo Ferrarese; Lucio Tremolizzo
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-08-31       Impact factor: 2.582

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.